Bicycle Therapeutics plc Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Bicycle Therapeutics plc (BCYC) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $27.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-17
- Bicycle Therapeutics plc valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $27.10M, a 39.69% increase from fiscal 2024.
- Bicycle Therapeutics plc valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $19.40M, a 26.79% decline from fiscal 2023.
- Bicycle Therapeutics plc valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $26.50M, a 38.74% increase from fiscal 2022.
- Bicycle Therapeutics plc valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $19.10M, a 3.24% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $27.10M 10-K · filed 2026-03-17 |
| 2024-12-31 | $19.40M 10-K · filed 2026-03-17 |
| 2023-12-31 | $26.50M 10-K · filed 2024-02-20 |
| 2022-12-31 | $19.10M 10-K · filed 2023-02-28 |
| 2021-12-31 | $18.50M 10-K · filed 2022-03-01 |
| 2020-12-31 | $8.00M 10-K · filed 2021-03-11 |
| 2017-12-31 | $2.50M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |